Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Study reveals structure of ribosomal assembly intermediate

Study reveals structure of ribosomal assembly intermediate

Moderate social drinking reduces risk of dementia and cognitive impairment

Moderate social drinking reduces risk of dementia and cognitive impairment

Modified Cdk5 enzyme triggers damage to nerve cell connections in human Alzheimer's brains

Modified Cdk5 enzyme triggers damage to nerve cell connections in human Alzheimer's brains

Gene therapy cocktail can treat inherited diseases with 'misfolded' proteins

Gene therapy cocktail can treat inherited diseases with 'misfolded' proteins

Survey: 35% of people in the UK fear cancer more than other life-threatening conditions

Survey: 35% of people in the UK fear cancer more than other life-threatening conditions

Viewpoints:  Health reform 'tax' vs. 'penalty'; super committee forecast; boomer tsunami

Viewpoints: Health reform 'tax' vs. 'penalty'; super committee forecast; boomer tsunami

Regular exercise could help prevent brain damage linked with Alzheimer's

Regular exercise could help prevent brain damage linked with Alzheimer's

Amorfix provides update on cancer therapeutic antibody programs

Amorfix provides update on cancer therapeutic antibody programs

Insight into how molecular motor proteins save energy

Insight into how molecular motor proteins save energy

La Jolla Institute's new RNAi Center to focus on genetics behind myriad diseases

La Jolla Institute's new RNAi Center to focus on genetics behind myriad diseases

Older people may be at risk for unhealthy over-exposure to iron

Older people may be at risk for unhealthy over-exposure to iron

Link between brain shrinkage, memory loss in Alzheimer's changes across age spectrum

Link between brain shrinkage, memory loss in Alzheimer's changes across age spectrum

Neurologist care may improve quality of life for people with Parkinson's

Neurologist care may improve quality of life for people with Parkinson's

BELLUS Health second quarter revenues increase to $719,000

BELLUS Health second quarter revenues increase to $719,000

Elderly women with sleep apnea more likely to develop dementia

Elderly women with sleep apnea more likely to develop dementia

Nottingham researchers to develop new early warning system for Alzheimer's

Nottingham researchers to develop new early warning system for Alzheimer's

New drug to prevent Alzheimer's could be tested on patients within six years

New drug to prevent Alzheimer's could be tested on patients within six years

AFA to host National Brain Game Challenge on September 25

AFA to host National Brain Game Challenge on September 25

EPO issues European patent for Rexahn's neurotherapeutic compositions

EPO issues European patent for Rexahn's neurotherapeutic compositions

Group Health study finds higher dementia risk with atrial fibrillation

Group Health study finds higher dementia risk with atrial fibrillation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.